Labshake search
Citations for Tocris :
101 - 150 of 213 citations for VIP Antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... the NMDA antagonist AP5 (3 μg/0.5 μl/side; Tocris Bioscience) to the DMS ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were incubated in the TRPA1 antagonist (HC-030031, Tocris #2896) for 15 minutes prior to imaging experiment.
-
bioRxiv - Immunology 2022Quote: ... 25-DHC (Cayman Biochemicals) or the GPR183-specific antagonist NIBR189 (50nM) (Tocris) was added to the lower chamber ...
-
bioRxiv - Cancer Biology 2021Quote: The selective CB2 inverse-antagonist (AM630) was purchased from Tocris (Bristol, UK). All other reagents and materials for cell cultures were obtained from standard suppliers.
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by application of bicuculline (50 µM, a GABAA receptor antagonist, Tocris) for 1 min to inhibit inhibitory synaptic inputs and activate synaptic glutamate receptors ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Immunology 2023Quote: ... SR144528 is a CB2R inverse agonist/antagonist and was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... Oxtr antagonist L-371257 (1 μm at working concentration, Tocris, Cat# 2410), or the same volume of DMSO as control were introduced into the ASCF solution by a pipette above the bubbler ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... The Avpr1b antagonist SSR149415 (1 μm at working concentration, Tocris, Cat# 6195), Oxtr antagonist L-371257 (1 μm at working concentration ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Neuroscience 2021Quote: ... and TCS-OX2-29 (TCS; OX2 receptor antagonist; 10 µM Tocris, Bristol, UK) were stored as 100 × concentrates at –20 ° C ...
-
bioRxiv - Neuroscience 2020Quote: Antagonists were bath applied at the following concentrations: D-APV (Tocris Bioscience, 50μM), NBQX (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... or the D1 receptor antagonist SCH 23390 hydrochloride (Tocris Bioscience, cat no: 0925) at a dose of 0.01 or 0.2 mg/kg ...
-
bioRxiv - Neuroscience 2019Quote: ... in 0.9% saline] or the ORX1R antagonist SB-334867 (50 nmol; Tocris, 1960) into the lateral ventricle 20 min prior to social play testing (Figure 1) ...
-
bioRxiv - Neuroscience 2022Quote: ... the following antagonists were added to the ACSF: SR-95531 (1 µM, Tocris), CGP-55845 (1 µM ...
-
Development of follicular dendritic cells in lymph nodes depends on retinoic acid mediated signalingbioRxiv - Immunology 2020Quote: ... mice were treated with the pan-RAR antagonist BMS493 (5mg/kg; Tocris Bioscience) or vehicle (DMSO ...
-
bioRxiv - Immunology 2022Quote: ... The GPR183-specific antagonist NIBR189 was from Tocris (Bio-Techne Corp, Minneapolis, MN).
-
bioRxiv - Neuroscience 2022Quote: ... cultures were treated with the ABCA1 antagonist PSC833 (1-10 μM; Tocris Bioscience) or vehicle control (DMSO ...
-
bioRxiv - Neuroscience 2022Quote: ... The NMDAR antagonist MK-801 (also known as dizocilpine, 0.1 mg/kg, Tocris), was dissolved in saline and administered 30 min before haloperidol ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor antagonist (10-5M Sb 258719, Tocris, CAS:1217674-10-6), 5-HT7 receptor agonist (10-5M AS-19 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Immunology 2023Quote: ... kisspeptin 234 (KISSIR ligand) and the PTK6 antagonist tilfrinib were purchased from Tocris. The GRK6 antagonist GRK-IN-1 was purchased from DC Chemicals ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA receptor antagonist gabazine (SR 95531 hydrobromide, Tocris, Wiesbaden-Nordenstadt, Germany, 5 μM) was bath-applied for 60 min after having recorded a minimum of 20 min stable baseline responses ...
-
bioRxiv - Neuroscience 2020Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents ...
-
bioRxiv - Neuroscience 2023Quote: ... and a cocktail of nicotinic antagonists (dihydro-ß-erythroidine (10 µM, Tocris, MN, USA), methyllycaconitine (0.1 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... Neurons were pretreated with 100 µM of the NRP-1 antagonist EG00229 (6986; Tocris) dissolved in DMSO prior to infection as described for Caco-2 cells26 ...
-
bioRxiv - Neuroscience 2023Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Genetics 2020Quote: ... serial dilutions of the dopaminergic and serotonergic antagonist amisulpride (Tocris, Bristol, UK, 71675-86-9) were prepared to give final concentrations of 0.05 mg/L ...
-
bioRxiv - Neuroscience 2021Quote: AM251 pharmacology: in experiments using the CB1 antagonist AM251 (3 µM) (Tocris and AdooQ biosciences), the drug (diluted in DMSO ...
-
bioRxiv - Neuroscience 2022Quote: ... We bath-applied the following drugs: picrotoxin (PTX) (GABAA receptor antagonist, 10µM, Tocris Bioscience, #1128) and strychnine hydrochloride (Strych ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Neuroscience 2023Quote: ... Cells were then treated with assay buffer containing the A2BR antagonist PSB603 (1 µM, Tocris), rolipram (30 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... Either the selective Y1-R antagonist BIBP3226 (1 μM; Cat.-No. 2707; Tocris, Bristol, UK) or NPY (1 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... The AMPA component was isolated by bath application of an NMDA antagonist (APV; 50μM, Tocris). NMDA component was obtained by digital subtraction of the AMPA-oEPSC from the dual component18 ...
-
bioRxiv - Neuroscience 2021Quote: ... The AMPAR component was isolated by bath application of an NMDAR antagonist (APV; 50 μM, Tocris)(Kasanetz & Manzoni ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2020Quote: ... β-funaltrexamine (β-FNA; an irreversible antagonist of the MORs) was obtained from Tocris (Bristol, UK). Stock solutions of β-FNA were prepared by dissolving the compound in the correct volume of distilled water to obtain 13.6 mM concentration of β-FNA ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT1A-R agonist 8-OH-DPAT or antagonist NAN-190 (NAN) were from Tocris (UK). Competition was performed at concentration between 10−11 to 10−5 M ...
-
bioRxiv - Neuroscience 2022Quote: The β3AR-selective antagonist SR59230A (2 mg/kg/day or 10 mg/kg/day; Tocris Bioscience) or vehicle (2:3 ratio of DMSO:0.9% saline ...
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfallsbioRxiv - Neuroscience 2023Quote: ... either alone or in the presence of the CB1R antagonist O-2050 (10 µM, Tocris #1655) as control ...
-
bioRxiv - Neuroscience 2024Quote: ... a non-selective opioid antagonist (0.5 mg/24 hours over 4 weeks, Tocris, Cat# 0599/100) or vehicle solution via an ALZET mini osmotic pump (Model 1004 ...
-
bioRxiv - Developmental Biology 2021Quote: ... The following signalling pathway inhibitors were employed: the WNT antagonist tankyrase inhibitor XAV 939 (1 μM, Tocris), the MEK1/2 inhibitor PD0325901 (1 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... a mixture of Ringer’s and 1 μM of the GABAB antagonist CGP 52432 (Cat Nr. 1246, Tocris) was topically applied and recordings were initiated after 30 min (Iurilli et al ...
-
bioRxiv - Cancer Biology 2019Quote: ... ADORA2b selective antagonist 4-(2,3,6,7-Tetrahydro-2, 6-dioxo-1-propyl-1H-purin-8-yl)-benzenesulfonic acid (PSB1115) (Tocris) (Lin et al. ...
-
bioRxiv - Biophysics 2022Quote: ... Non-specific binding was determined in the presence of 10µM of the selective β3 antagonist L748337 (TOCRIS). Samples were incubated in 96-well plate sealed with transparent Topseal for 2h at 25°C with gentle agitation ...